Briggs W. Morrison
2021
In 2021, Briggs W. Morrison earned a total compensation of $3.9M as Chief Executive Officer at Syndax Pharmaceuticals, a 80% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $309,280 |
|---|---|
| Option Awards | $2,968,473 |
| Salary | $618,563 |
| Other | $8,000 |
| Total | $3,904,316 |
Morrison received $3M in option awards, accounting for 76% of the total pay in 2021.
Morrison also received $309.3K in non-equity incentive plan, $618.6K in salary and $8K in other compensation.
Rankings
In 2021, Briggs W. Morrison's compensation ranked 3,430th out of 12,406 executives tracked by ExecPay. In other words, Morrison earned more than 72.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,430 out of 12,406 | 72nd |
Division Manufacturing | 1,394 out of 5,494 | 75th |
Major group Chemicals And Allied Products | 564 out of 2,369 | 76th |
Industry group Drugs | 502 out of 2,090 | 76th |
Industry Pharmaceutical Preparations | 349 out of 1,537 | 77th |
Source: SEC filing on March 29, 2022.
Morrison's colleagues
We found three more compensation records of executives who worked with Briggs W. Morrison at Syndax Pharmaceuticals in 2021.
News
Syndax Pharmaceuticals CEO Briggs Morrison's 2021 pay jumps 80% to $3.9M
March 29, 2022
Syndax Pharmaceuticals CFO Daphne Karydas receives $3.1M in 2020
April 1, 2021
Syndax Pharmaceuticals COO Michael Metzger's 2019 pay jumps 77% to $2.7M
April 29, 2020
Syndax Pharmaceuticals CEO Briggs Morrison's 2018 pay jumps 24% to $2.1M
April 30, 2019